Tadalafil
Product Images NDC 50090-4247

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-4247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904247)

Packaging label for Tadalafil 20 mg tablets by A-S Medication Solutions. The label shows the product NDC as 50090-4247-0 and the package contains 30 tablets. It instructs storage at 68 to 77 degrees Fahrenheit and includes a dosage package insert QR code. The label also lists the distributor address and regulatory information.*

FDA Label Image

Tadalafilcamberlogo1 (Tadalafilcamberlogo1)

FDA Label Image

Tadalafilcamberlogo1 (Tadalafilcamberlogo2)

FDA Label Image

Tadalafilfigure1 (Tadalafilfigure1)

A line graph showing the mean change from baseline in meters over 16 weeks comparing Tadalafil 40 mg (N=79) and placebo (N=82). The graph includes data points at weeks 0, 4, 8, 12, and 16 with error bars and significance levels indicated by asterisks. The Tadalafil group shows an increasing trend, while the placebo group remains relatively flat after week 4.*

FDA Label Image

Tadalafilfigure2 (Tadalafilfigure2)

A forest plot showing the placebo-adjusted mean change in 6-minute walk distance (meters) with 95% confidence intervals for Tadalafil 40 mg, analyzed across various subject subgroups such as bosentan use, PAH etiology, baseline walk distance, gender, age, and WHO functional class. The plot includes the number of subjects in each group and plots mean changes with error bars on a horizontal axis ranging approximately from -100 to 200 meters.*

FDA Label Image

Tadalafilfigure3 (Tadalafilfigure3)

A line graph depicting the percentage without clinical worsening over time in days, comparing Tadalafil 40 mg, Tadalafil 20 mg, and placebo. The y-axis shows percentage without clinical worsening, ranging from 0 to 100%, and the x-axis represents time to clinical worsening in days, up to 150 days. The graph includes three distinct lines representing the treatments.*

FDA Label Image

Tasalafilstructure (Tadalafilstructure)

Chemical structure of Tadalafil showing its molecular arrangement with fused rings and heteroatoms, matching the active ingredient of the product from A-S Medication Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.